We are a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. Our goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. Our lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. Our pipeline also includes two preclinical-stage product candidates:CASC-578, a Chk1 kinase inhibitor, andCASC-674, an antibody program against an immuno-oncology target known as TIGIT.
Company profile
Ticker
ONTY
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Icon • Syneos Health • Medpace • Incyte • Zymergen • OmniAb ...
Former names
Biomira CORP, Oncothyreon Inc.
SEC CIK
Corporate docs
IRS number
260868560
ONTY stock data
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
11 Apr 19
CT ORDER
Confidential treatment order
22 May 18
15-12B
Securities registration termination
22 Mar 18
EFFECT
Notice of effectiveness
21 Mar 18
EFFECT
Notice of effectiveness
21 Mar 18
EFFECT
Notice of effectiveness
21 Mar 18
EFFECT
Notice of effectiveness
21 Mar 18
25-NSE
Exchange delisting
9 Mar 18
8-K
Completion of Acquisition or Disposition of Assets
9 Mar 18
POS AM
Prospectus update (post-effective amendment)
9 Mar 18
Latest ownership filings
SC 13G/A
Cascadian Therapeutics, Inc.
9 Apr 18
SC 13D/A
Cascadian Therapeutics, Inc.
19 Mar 18
4
DANIEL K SPIEGELMAN
13 Mar 18
4
Steven P James
13 Mar 18
4
Anthony A. Jr. Florence
13 Mar 18
4
Peter W. Sonsini
13 Mar 18
4
JULIA MARIE EASTLAND
13 Mar 18
4
Robert Azelby
13 Mar 18
4
Luke Nathaniel Walker
13 Mar 18
4
JOSHUA MAKOWER
13 Mar 18
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|